JUST IN: Vaccine advisers to the FDA have voted in favor of granting emergency use authorization for Pfizer's Covid-19 vaccine in children ages 5 to 11
Members of the FDA's Vaccines and Related Biological Products Advisory Committee agreed that the benefits of vaccinating younger children appeared to outweigh the risks, but some members appeared troubled about voting to vaccinate a large population of younger children based on studies of a few thousand."It is reassuring to me that we are giving a lower dose," said Dr. Paul Offit, a vaccine expert at Children's Hospital of Philadelphia.
The FDA had said that, under most of the scenarios it projected, the benefits of vaccinating younger children would outweigh any risks and Pfizer said clinical trials showed the vaccine was more than 90% effective in preventing symptomatic infection in children.The FDA will now take the committee's vote under consideration.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Fresh lockdowns in China as local Covid-19 infections spread to 11 provincesAuthorities in northern China are reimposing lockdowns and other emergency measures to curb the spread of coronavirus, with health officials warning of a worsening outbreak after the country recorded more than 100 cases across 11 provinces over the last week.
Les mer »
Moderna says its COVID-19 vaccine is protective, safe in kids 6 to 11Moderna said its two-dose vaccine generated virus-neutralizing antibodies in children and safety was comparable to what was previously seen in clinical trials of adolescents and adults.
Les mer »
Moderna Says Its Low-Dose COVID-19 Vaccine Works For Kids 6 To 11Children who received the vaccine developed virus-fighting antibodies similar to levels that young adults produce after full-strength shots, Moderna said.
Les mer »
Moderna Data Shows Covid-19 Vaccine Produced Strong Immune Response in 6- to 11-Year-OldsModerna said it would submit the results from an interim study to health regulators in the U.S., Europe and elsewhere in seeking authorization for 6- to 11-year-olds.
Les mer »
FDA Advisers Back Pfizer’s COVID-19 Vaccine For Young Kids Ages 5-11U.S. health advisers have endorsed kid-size doses of Pfizer's COVID-19 vaccine for younger children.
Les mer »
U.S. FDA advisers weigh Pfizer/BioNTech COVID-19 vaccine in childrenAn expert panel will weigh authorization of Pfizer Inc and BioNTech's COVID-19 vaccine for U.S. children aged 5 to 11 on Tuesday as it prepares to vote on a recommendation for the federal Food and Drug Administration.
Les mer »